Drug Shortage Report for TEVA-SOLIFENACIN
Report ID | 152417 |
Drug Identification Number | 02397919 |
Brand name | TEVA-SOLIFENACIN |
Common or Proper name | SOLIFENACIN 10MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-01-05 |
Estimated end date | 2022-08-30 |
Actual end date | 2022-08-18 |
Shortage status | Resolved |
Updated date | 2022-08-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v25 | 2022-08-19 | English | Compare |
v24 | 2022-08-18 | French | Compare |
v23 | 2022-08-18 | English | Compare |
v22 | 2022-08-15 | French | Compare |
v21 | 2022-08-15 | English | Compare |
v20 | 2022-07-19 | French | Compare |
v19 | 2022-07-19 | English | Compare |
v18 | 2022-06-30 | French | Compare |
v17 | 2022-06-30 | English | Compare |
v16 | 2022-06-09 | French | Compare |
v15 | 2022-06-09 | English | Compare |
v14 | 2022-06-03 | French | Compare |
v13 | 2022-06-03 | English | Compare |
v12 | 2022-05-12 | French | Compare |
v11 | 2022-05-12 | English | Compare |
v10 | 2022-05-05 | French | Compare |
v9 | 2022-05-05 | English | Compare |
v8 | 2022-02-10 | French | Compare |
v7 | 2022-02-10 | English | Compare |
v6 | 2022-01-27 | French | Compare |